Merit Financial Group’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Merit Financial Group’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-58,900	Closed	-$77.2K	–	843
2023 Q3	$77.2K	Sell	58,900 -2,000	-3%	-$2.92K	﹤0.01%	725
2023 Q2	$107K	Hold	60,900	–	–	﹤0.01%	723
2023 Q1	$102K	Hold	60,900	–	–	﹤0.01%	606
2022 Q4	$182K	Buy	+60,900	New	+$239K	0.01%	630

Merit Financial Group's MIRO Position: Q4 2023 in Review

Merit Financial Group sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 58,900 shares — an estimated $77.2K sold.

Merit Financial Group first reported a position in MIRO in Q4 2022 and held it in 4 quarters. The position peaked at $182K in Q4 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Merit Financial Group reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Merit Financial Group sold 58,900 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $77.2K.
Merit Financial Group first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Merit Financial Group's Miromatrix Medical Inc. Common Stock position peaked at $182K in Q4 2022.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Merit Financial Group's 13F filing for Q4 2023, filed 6 Feb 2024.